836
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines

, &
Pages 1205-1219 | Received 09 Jan 2019, Accepted 18 Jun 2019, Published online: 24 Jul 2019

References

  • Abe T, Ishiai M, Hosono Y, Yoshimura A, Tada S, Adachi N, Koyama H, Takata M, Takeda S, Enomoto T, et al. 2008. KU70/80, DNA-PKcs, and Artemis are essential for the rapid induction of apoptosis after massive DSB formation. Cell Signal. 20:1978–1985.
  • Arlander SJ, Greene BT, Innes CL, Paules RS. 2008. DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells. Cancer Res. 68:89–97.
  • Auckley DH, Crowell RE, Heaphy ER, Stidley CA, Lechner JF, Gilliland FD, Belinsky SA. 2001. Reduced DNA-dependent protein kinase activity is associated with lung cancer. Carcinogenesis. 22:723–727.
  • Azad A, Bukczynska P, Jackson S, Haput Y, Cullinane C, McArthur GA, Solomon B. 2014. Co-targeting deoxyribonucleic acid-dependent protein kinase and poly(adenosine diphosphate-ribose) polymerase-1 promotes accelerated senescence of irradiated cancer cells. Int J Radiat Oncol Biol Phys. 88:385–394.
  • Azad A, Jackson S, Cullinane C, Natoli A, Neilsen PM, Callen DF, Maira S-M, Hackl W, McArthur GA, Solomon B. 2011. Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells. Mol Cancer Res. 9:1696–1707.
  • Beskow C, Skikuniene J, Holgersson Å, Nilsson B, Lewensohn R, Kanter L, Viktorsson K. 2009. Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Br J Cancer. 101:816–821.
  • Castedo M, Perfettini J-L, Roumier T, Valent A, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G, Medema R, et al. 2004. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene. 23:4362–4370.
  • Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, Qin J, Chen DJ. 2002. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 16:2333–2338.
  • Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 1999. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature. 401:616–620.
  • Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, Morotomi-Yano K, Botvinick E, Qin J, Chen DJ. 2005. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem. 280:14709–14715.
  • Chen BP, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H, Lobrich M, Shiloh Y, Chen DJ. 2007. Ataxia telangiectasia mutated (ATM) is essential for DNAPKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem. 282:6582–6587.
  • Chiarugi V. 1997. PI3K signal and DNA repair: a short commentary. Pharmacol Res. 35:263–265.
  • Deriano L, Guipaud O, Merle-Beral H, Binet JL, Ricoul M, Potocki-Veronese G, Favaudon V, Maciorowski Z, Muller C, Salles B, et al. 2005. Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway. Blood. 105:4776–4783.
  • Dixon WJ, Mood AM. 1946. The statistical sign test. J Am Stat Assoc. 41:557–566.
  • Dodson H, Wheatley SP, Morrison CG. 2007. Involvement of centrosome amplification in radiation-induced mitotic catastrophe. Cell Cycle. 6:364–370.
  • Gerard C, Debruyne C. 2009. Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer. Mol Oncol. 3:409–424.
  • Hafsi H, Dillon MT, Barker HE, Kyula JN, Schick U, Paget JT, Smith HG, Pedersen M, McLaughlin M, Harrington KJ. 2018. Combined ATR and DNA-PK inhibition radiosensitizes tumor cells independently of their p53 status. Front Oncol. 8:245.
  • Hernández L, Terradas M, Martín M, Tusell L, Genescà A. 2013. Highly sensitive automated method for DNA damage assessment: gamma-H2AX foci counting and cell cycle sorting. Int J Mol Sci. 14:15810–15826.
  • Hollick JJ, Golding BT, Hardcastle IR, Martin N, Richardson C, Rigoreau LJM, Smith GCM, Griffin RJ. 2003. 2,6-Disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-dependent protein kinase (DNA-PK). Bioorg Med Chem Lett. 13:3083–3086.
  • Hsu FM, Zhang S, Chen BP. 2012. Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment. Transl Cancer Res. 1:22–34.
  • Hu S, Qu Y, Xu X, Xu Q, Geng J, Xu J. 2013. Nuclear surviving and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array. PloS One. 8:e74161.
  • Huang X, Tran T, Zhang L, Hatcher R, Zhang P. 2005. DNA damageinduced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci USA. 102:1065–1070.
  • Leahy JJJ, Golding BT, Griffin RJ, Hardcastle IR, Richardson C, Rigoreau L, Smith GCM. 2004. Identification of a highly potent and selective DNA dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg Med Chem Lett. 14:6083–6087.
  • Lee K-J, Lin Y-F, Chou H-Y, Yajima H, Fattah KR, Lee S-C, Chen BPC. 2011. Involvement of DNA-dependent protein kinase in normal cell cycle progression through mitosis. J Biol Chem. 286:12796–12802.
  • Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature. 396:643–649.
  • Lieber MR, Ma Y, Pannicke U, Schwarz K. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol. 4:712–720.
  • MacPhail SH, Banáth JP, Yu Y, Chu E, Olive PL. 2003. Cell cycle-dependent expression of phosphorylated histone H2AX: reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat Res. 159:759–767.
  • Maity A, Kao GD, Muschel RJ, McKenna WG. 1997. Potential molecular targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys. 37:639–653.
  • Nutley BP, Smith NF, Hayes A, Kelland LR, Brunton L, Golding BT, Smith GCM, Martin NMB, Workman P, Raynaud FI. 2005. Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026. Br J Cancer. 93:1011–1018.
  • Olive PL, Banáth JP. 2004. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys. 58:331–335.
  • Pan H, Zuo C, Mao N. 2007. Expression and clinical significance of Ku70, Ku80 and DNA-PKcs proteins in patients with stageI-II non-small cell lung cancer by tissue microarray. Zhongguo Fei Ai Za Zhi. 10:203–205.
  • Price BD, Youmell MB. 1996. The phosphatidylinositol 3-kinase inhibitor Wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res. 56:246–250.
  • Sak A, Stuschke M. 2010. Use of γH2AX and other biomarkers of double-strand breaks during radiotherapy. Semin Radiat Oncol. 20:223–231.
  • Sak A, Stuschke M, Wurm R, Schroeder G, Sinn B, Wolf G, Budach V. 2002. Selective inactivation of DNA-dependent protein kinase with antisense oligodeoxynucleotides: consequences for the rejoining of radiation-induced DNA double-strand breaks and radiosensitivity of human cancer cell lines. Cancer Res. 62:6621–6624.
  • Shang Z-F, Huang B, Xu Q-Z, Zhang S-M, Fan R, Liu X-D, Wang Y, Zhou P-K. 2010. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage. Cancer Res. 70:3657–3666.
  • Shao C-J, Fu J, Shi H-L, Mu Y-G, Chen Z-P. 2008. Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas. J Neurooncol. 89:27–35.
  • Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, Halbrook J, Kesicki EA, Kashishian A, Hallahan DE, et al. 2005. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res. 65:4987–4992.
  • Shintani S, Mihara M, Li C, Nakahara Y, Hino S, Nakashiro K-i, Hamakawa H. 2003. Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci. 94:894–900.
  • Someya M, Sakata KI, Matsumoto Y, Kamdar RP, Kai M, Toyota M, Hareyama M. 2011. The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer. Br J Cancer. 104:1724–1729.
  • Stapper NJ, Stuschke M, Sak A, Stüben G. 1995. Radiation-induced apoptosis in human sarcoma and glioma cell lines. Int J Cancer. 62:58–62.
  • Stronach EA, Chen M, Maginn EN, Agarwal R, Mills GB, Wasan H, Gabra H. 2011. DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance. Neoplasia. 13:1069–1080.
  • Stuschke M, Sak A, Wurm R, Sinn B, Wolf G, Stüben G, Budach V. 2002. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint. Int J Radiat Biol. 78:807–819.
  • Wonsey DR, Follettie MT. 2005. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 65:5181–5189.
  • Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J. 2008. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer. 112:2756–2764.
  • Yu T, MacPhail SH, Banáth JP, Klokov D, Olive PL. 2006. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair. 5:935–946.
  • Yu L, Shang ZF, Hsu FM, Zhang Z, Tumati V, Lin YF, Chen BP, Saha D. 2015. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. Oncotarget. 6:3848–3860.
  • Yu S, Xiong Y, Tian S. 2003. The expression of DNA-PKcs in non-small cell lung cancer and its relationship with apoptosis associated proteins. Zhongguo Fei Ai Za Zhi. 6:356–359.
  • Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ, Calvert AH, Newell DR, Smith GCM, Curtin NJ, et al. 2006. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res. 66:5354–5362.
  • Zhuang W, Li B, Long L, Chen L, Huang Q, Liang Z-q. 2011. Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy. Brain Res. 1371:7–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.